Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F03V4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,635
Award facts
- Contract value 100% obligated
- $21,634.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,634.93 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, with a completion date of January 30, 2026. The contract calls for the delivery of RINVOQ ER 15 MG tablets in units of 30 tablets. The award was made on a firm fixed-price basis with no set-aside designation, indicating full and open competition. Performance will occur at AmerisourceBergen Drug Corp's facility in Conshohocken, Pennsylvania, where the company's corporate office is headquartered.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems, and regularly fulfills delivery orders for specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F03V4?
SPE2DR26F03V4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F03V4 worth?
The government has obligated $21,635 on SPE2DR26F03V4.
Is contract SPE2DR26F03V4 an order under another contract?
Yes. SPE2DR26F03V4 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03V4 competed?
The extent of competition for SPE2DR26F03V4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award